Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387207917> ?p ?o ?g. }
- W4387207917 endingPage "S102" @default.
- W4387207917 startingPage "S102" @default.
- W4387207917 abstract "Glioblastoma (GBM) is an incurable brain tumor comprised of dynamic malignant cell states and microenvironment components that underlie treatment resistance. Here we use genome-wide CRISPR/Cas9 functional genomics to define biological drivers and therapeutic vulnerabilities across human and mouse GBM models. To interrogate these mechanisms in the context of the tumor microenvironment and in vivo physiology, we established in vivo Perturb-seq intracranially, a technique coupling functional genomics with single cell transcriptomics, where each cell is an individual experiment.Orthotopic intracranial tumor models were established using human (GBM6, GBM43) or mouse (GL261, SB28) GBM cells stably expressing CRISPR interference (CRISPRi) machinery. Perturb-seq target selection for phenotyping of gene-treatment interactions was performed using genome-wide CRISPRi screens ± radiotherapy in cell cultures. Dual sgRNA lentivirus libraries were transduced either ex vivo prior to intracranial GBM cell transplantation or in vivo using intratumor convection enhanced delivery (CED). Transcriptional phenotyping was performed using single-cell RNA-seq with CRISPR direct capture following focal brain radiotherapy (2 Gy x 5) or mock treatment. GBM cell states were validated using single-nucleus RNA-seq data from 86 primary-recurrent patient-matched GBMs. Mechanistic and functional validation was performed using small molecule inhibitors, immunohistochemistry, clonogenic assays, and in vivo survival experiments.In vivo Perturb-seq ± radiotherapy of 48 genes underlying GBM radiotherapy responses, which were enriched for DNA damage response and metabolic pathways, was performed in > 425,000 single cells. Radiotherapy induced 16 distinct GBM cell states, and genetic perturbations reprogrammed these cell states in a treatment-dependent fashion. Quantitative modeling of gene/radiotherapy interactions using high dimensional manifolds revealed in vivo-specific genetic dependencies. We revealed a critical role for Prkdc, the catalytic subunit of DNA-dependent protein kinase (DNA-PK), as a radiotherapy sensitizer through regulation of cell intrinsic growth and oxidative stress pathways, and cell extrinsic interferon and signaling pathways that altered cell-cell interactions in vivo. These pathways were also disrupted in single-nucleus RNA-seq analysis of post-radiotherapy human GBM tumors. Inhibition of Prkdc using a Food and Drug Administration approved small molecule sensitized GBM cells to radiotherapy and extended survival in mice harboring human intracranial xenografts.We establish in vivo Perturb-seq in orthotopic GBM models as a platform for simultaneous functional genomic discovery and characterization of therapeutic targets, revealing an underappreciated role for Prkdc in GBM tumors in vivo that is targetable using small molecules. These tools are adaptable for a wide range of disease models and treatment modalities." @default.
- W4387207917 created "2023-09-30" @default.
- W4387207917 creator A5006262715 @default.
- W4387207917 creator A5007540843 @default.
- W4387207917 creator A5026160956 @default.
- W4387207917 creator A5030024429 @default.
- W4387207917 creator A5035219354 @default.
- W4387207917 creator A5047028132 @default.
- W4387207917 creator A5050048093 @default.
- W4387207917 creator A5050863961 @default.
- W4387207917 creator A5059909223 @default.
- W4387207917 creator A5065255856 @default.
- W4387207917 creator A5073603294 @default.
- W4387207917 creator A5074832167 @default.
- W4387207917 creator A5075747858 @default.
- W4387207917 creator A5079425092 @default.
- W4387207917 creator A5084504680 @default.
- W4387207917 creator A5084510100 @default.
- W4387207917 creator A5091788653 @default.
- W4387207917 date "2023-10-01" @default.
- W4387207917 modified "2023-10-17" @default.
- W4387207917 title "Identifying Gene-Treatment Interactions and Targetable Radiation Vulnerabilities in Glioblastoma through Coupling of In Vivo CRISPR Perturbation and Single Cell Transcriptomics" @default.
- W4387207917 doi "https://doi.org/10.1016/j.ijrobp.2023.06.057" @default.
- W4387207917 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37784271" @default.
- W4387207917 hasPublicationYear "2023" @default.
- W4387207917 type Work @default.
- W4387207917 citedByCount "0" @default.
- W4387207917 crossrefType "journal-article" @default.
- W4387207917 hasAuthorship W4387207917A5006262715 @default.
- W4387207917 hasAuthorship W4387207917A5007540843 @default.
- W4387207917 hasAuthorship W4387207917A5026160956 @default.
- W4387207917 hasAuthorship W4387207917A5030024429 @default.
- W4387207917 hasAuthorship W4387207917A5035219354 @default.
- W4387207917 hasAuthorship W4387207917A5047028132 @default.
- W4387207917 hasAuthorship W4387207917A5050048093 @default.
- W4387207917 hasAuthorship W4387207917A5050863961 @default.
- W4387207917 hasAuthorship W4387207917A5059909223 @default.
- W4387207917 hasAuthorship W4387207917A5065255856 @default.
- W4387207917 hasAuthorship W4387207917A5073603294 @default.
- W4387207917 hasAuthorship W4387207917A5074832167 @default.
- W4387207917 hasAuthorship W4387207917A5075747858 @default.
- W4387207917 hasAuthorship W4387207917A5079425092 @default.
- W4387207917 hasAuthorship W4387207917A5084504680 @default.
- W4387207917 hasAuthorship W4387207917A5084510100 @default.
- W4387207917 hasAuthorship W4387207917A5091788653 @default.
- W4387207917 hasConcept C104317684 @default.
- W4387207917 hasConcept C117262875 @default.
- W4387207917 hasConcept C126322002 @default.
- W4387207917 hasConcept C141231307 @default.
- W4387207917 hasConcept C1491633281 @default.
- W4387207917 hasConcept C150194340 @default.
- W4387207917 hasConcept C151730666 @default.
- W4387207917 hasConcept C161078062 @default.
- W4387207917 hasConcept C162317418 @default.
- W4387207917 hasConcept C189206191 @default.
- W4387207917 hasConcept C207001950 @default.
- W4387207917 hasConcept C26291073 @default.
- W4387207917 hasConcept C2779343474 @default.
- W4387207917 hasConcept C502942594 @default.
- W4387207917 hasConcept C509974204 @default.
- W4387207917 hasConcept C54355233 @default.
- W4387207917 hasConcept C70721500 @default.
- W4387207917 hasConcept C71924100 @default.
- W4387207917 hasConcept C86803240 @default.
- W4387207917 hasConcept C98108389 @default.
- W4387207917 hasConceptScore W4387207917C104317684 @default.
- W4387207917 hasConceptScore W4387207917C117262875 @default.
- W4387207917 hasConceptScore W4387207917C126322002 @default.
- W4387207917 hasConceptScore W4387207917C141231307 @default.
- W4387207917 hasConceptScore W4387207917C1491633281 @default.
- W4387207917 hasConceptScore W4387207917C150194340 @default.
- W4387207917 hasConceptScore W4387207917C151730666 @default.
- W4387207917 hasConceptScore W4387207917C161078062 @default.
- W4387207917 hasConceptScore W4387207917C162317418 @default.
- W4387207917 hasConceptScore W4387207917C189206191 @default.
- W4387207917 hasConceptScore W4387207917C207001950 @default.
- W4387207917 hasConceptScore W4387207917C26291073 @default.
- W4387207917 hasConceptScore W4387207917C2779343474 @default.
- W4387207917 hasConceptScore W4387207917C502942594 @default.
- W4387207917 hasConceptScore W4387207917C509974204 @default.
- W4387207917 hasConceptScore W4387207917C54355233 @default.
- W4387207917 hasConceptScore W4387207917C70721500 @default.
- W4387207917 hasConceptScore W4387207917C71924100 @default.
- W4387207917 hasConceptScore W4387207917C86803240 @default.
- W4387207917 hasConceptScore W4387207917C98108389 @default.
- W4387207917 hasIssue "2" @default.
- W4387207917 hasLocation W43872079171 @default.
- W4387207917 hasLocation W43872079172 @default.
- W4387207917 hasOpenAccess W4387207917 @default.
- W4387207917 hasPrimaryLocation W43872079171 @default.
- W4387207917 hasRelatedWork W1982873976 @default.
- W4387207917 hasRelatedWork W2026592619 @default.
- W4387207917 hasRelatedWork W2078743855 @default.
- W4387207917 hasRelatedWork W2274502064 @default.
- W4387207917 hasRelatedWork W2467822028 @default.
- W4387207917 hasRelatedWork W2577994754 @default.
- W4387207917 hasRelatedWork W2899672494 @default.
- W4387207917 hasRelatedWork W2950723166 @default.